Acquisition of Sagent Pharmaceuticals Inc (NASDAQ:SGNT) Under Investigation for Investors

San Diego, CA -- (SBWIRE) -- 07/20/2016 -- The acquisition of Sagent Pharmaceuticals is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:SGNT shares, concerning whether the takeover of Sagent Pharmaceuticals Inc by Nichi-Iko Pharmaceutical Co., Ltd is unfair to NASDAQ:SGNT stockholders.